SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 140 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q2 2018. The put-call ratio across all filers is 1.54 and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 2,200,000 | $6,072,000 | 2.38% |
| GREAT POINT PARTNERS LLC | 2,175,000 | $6,003,000 | 2.15% |
| Belmont Global Advisors, Inc. | 400,000 | $1,104,000 | 1.12% |
| Trellus Management Company, LLC | 162,900 | $450,000 | 0.78% |
| PURA VIDA INVESTMENTS, LLC | 572,800 | $1,581,000 | 0.72% |
| DAFNA Capital Management LLC | 294,563 | $813,000 | 0.70% |
| Twin Securities, Inc. | 1,687,115 | $4,656,000 | 0.58% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 1,000,000 | $2,760,000 | 0.33% |
| WALL STREET ASSOCIATES | 269,300 | $743,000 | 0.31% |
| Paulson & Co. | 11,090,000 | $30,608,000 | 0.23% |